| Item no.: | 40134 |
|---|---|
| Active ingredient: | Cross-linked hyaluronic acid (IPN-like technology) + lidocaine |
| Concentration: | 20 mg/g HA, 0,3 % lidocaine |
| Format: | 2 × 1 ml syringes |
| Needles included: | 4 × 30G needles |
| Injection depth: | Mid to deep dermis |
| Duration: | 6 to 12 months |
| Indication: | Glabella and nasolabial folds, lips, marionette lines, scars, hands |
| Technology: | IPN-like technology (Vivacy) |
| Manufacturer: | Laboratoires Vivacy, France |
| Country of origin: | France |
| Certification: | CE Medical – class III |
CE-marked medical device
LOT number and Declaration of Conformity accompany every shipment for your patient records.
The product information below is reserved for approved clinics. Log in
Ships from our Norwegian warehouse, typically 1 to 2 business days.
Sterile and lot-controlled goods cannot be returned for patient-safety reasons. Contact us for defects or transit damage.
This product Stylage Bi-SOFT M
|
Teosyal RHA Kiss
|
Lumifil L-Kiss (1x1ml)
| |
|---|---|---|---|
| Price | Log in to see price | Log in to see price | Log in to see price |
| Manufacturer | Stylage | Teosyal | Lumifil |
| Availability | In stock | Out of stock – Temporarily sold out | In stock |
| CE marking | CE marked | CE marked | CE marked |
| Active ingredient | Cross-linked hyaluronic acid (IPN-like technology) + lidocaine | Cross-linked hyaluronic acid (RHA® technology) + lidocaine | Hyaluronic acid + lidocaine |
| Concentration | 20 mg/g HA, 0,3 % lidocaine | 23 mg/ml HA, 0.3% lidocaine | ~20 mg/ml HA, 0,3 % lidocaine |
| Format | 2 × 1 ml syringes | 2 × 0,7 ml syringes | 1 × 1 ml pre-filled syringe |
| Injection depth | Mid to deep dermis | Labial mucosa (lips) or mid-dermis (perioral lines) | Superficial to deep dermis |
| Duration | 6 to 12 months | 6 to 9 months | 6 to 12 months |
| Indication | Glabella and nasolabial folds, lips, marionette lines, scars, hands | Lip volume and shape, perioral lines, lip contour | Lip volume and shape, perioral lines, lip contour |
| Technology | IPN-like technology (Vivacy) | Teoxane's RHA® technology (Resilient Hyaluronic Acid) | Patented technology with uniform HA particles |
| Manufacturer | Laboratoires Vivacy, France | Teoxane, Switzerland | BNC Korea, South Korea |
| Country of origin | France | – | South Korea |
| Certification | CE Medical – class III | CE Medical – class III | CE Medical – class III |
| View product | View product |
No reviews yet. Be the first to share your experience with this product.
We supply original products from leading brands, fully traceable.
CE marking, Declaration of Conformity and LOT numbers ready for your compliance archive.
A knowledgeable team that knows the protocols and replies fast.